Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic maculopathies

T S Stevens

    International Ophthalmology Clinics
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Diabetic maculopathy causes vision loss through intraretinal or vitreoretinal changes. Treatments include photocoagulation for edema and vitreous surgery for traction, though macular heterotopia lacks effective treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2001
    Same author

    Occult choroidal neovascularization in age-related macular degeneration. A natural history study.

    Archives of ophthalmology (Chicago, Ill. : 1960)·1997
    Same author

    Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial.

    Archives of ophthalmology (Chicago, Ill. : 1960)·1996
    Same author

    Tuberculous choroiditis diagnosed by chorioretinal endobiopsy.

    American journal of ophthalmology·1991
    Same author

    Clinicopathologic correlation of diode laser burns in monkeys.

    Archives of ophthalmology (Chicago, Ill. : 1960)·1991
    Same author

    Immunocytochemical study of an eye with proliferative vitreoretinopathy and retinal tacks.

    Retina (Philadelphia, Pa.)·1990
    Same journal

    Home Tonometry and Perimetry: Addressing an Unmet Need in Glaucoma Care.

    International ophthalmology clinics·2026
    Same journal

    Bleb Revision Techniques for Hypotony Maculopathy: A Review.

    International ophthalmology clinics·2026
    Same journal

    Cyclodialysis Cleft Closure Following Suprachoroidal Spacer Implantation.

    International ophthalmology clinics·2026
    Same journal

    Descemet Membrane Detachment During Ab-Interno Canaloplasty.

    International ophthalmology clinics·2026
    Same journal

    Inflammatory Keratitis and IOP Spike After Repeat SLT in Pseudoexfoliation Glaucoma: Case Report and Literature Review.

    International ophthalmology clinics·2026
    Same journal

    Beyond the Bottle: Lessons From the Laser in Glaucoma and Ocular Hypertension Trial.

    International ophthalmology clinics·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Diabetic Retinopathy Research

    Background:

    • Diabetic maculopathy is a leading cause of vision loss in diabetic patients.
    • Pathological changes are categorized into intraretinal and vitreoretinal maculopathies.

    Purpose of the Study:

    • To classify and describe the clinical manifestations of diabetic maculopathy.
    • To outline current treatment strategies for different types of diabetic maculopathy.

    Main Methods:

    • Clinical classification of diabetic maculopathy into intraretinal and vitreoretinal subtypes.
    • Description of clinical signs such as macular edema, exudative maculopathy, epiretinal membranes, and macular heterotopia.
    • Review of treatment modalities including photocoagulation and vitreous surgery.

    Main Results:

    Related Experiment Videos

    • Intraretinal maculopathies result from capillary hyperpermeability or vascular shutdown, presenting as edema or ischemia.
    • Vitreoretinal maculopathies stem from vitreoretinal traction, leading to epiretinal membranes or detachment.
    • Photocoagulation is used for edema/exudation; vitreous surgery for tractional detachment and contracted membranes.

    Conclusions:

    • Diabetic maculopathy encompasses diverse pathological changes affecting the macula.
    • Treatment strategies are tailored to the specific type of maculopathy, with varying success rates.
    • Further research is needed for effective treatments for conditions like macular heterotopia.